Sodium Thiosulfate Injection USP 250 mg

Sodium Thiosulfate Injection USP 250 mg is a sterile solution used for various medical purposes. This intravenous solution is manufactured by Hope Pharmaceuticals Ltd. in Canada.

Sodium Thiosulfate Injection is commonly used as an antidote for cyanide poisoning. It works by converting cyanide into less toxic compounds that can be easily excreted by the body. Additionally, it may be used in the treatment of calciphylaxis, a condition characterized by calcium deposits in the skin and blood vessels. The primary use of Sodium Thiosulfate is to provide rapid detoxification in cases of poisoning or toxicity.

When administered intravenously, Sodium Thiosulfate Injection may cause common side effects such as nausea, vomiting, and headache. Some individuals might experience dizziness or a metallic taste in the mouth. These effects are generally mild and transient, but severe reactions are rare. Always consult a healthcare provider for any persistent or concerning symptoms.

Sodium Thiosulfate Injection should be handled with care and administered by a healthcare professional. It is important to follow proper storage and handling guidelines to maintain its efficacy. Patients with known allergies to any of the components should avoid its use. Always inform your healthcare provider about any pre-existing conditions or medications you are taking before starting treatment.

Sodium Thiosulfate Injection may interact with certain medications, including those that affect kidney function or blood pressure. It is advisable to avoid alcohol consumption while undergoing treatment. Always consult a healthcare provider for personalized advice on potential interactions with other medications or supplements.